USE OF PALLIATIVE END-POINTS TO EVALUATE THE EFFECTS OF MITOXANTRONE AND LOW-DOSE PREDNISONE IN PATIENTS WITH HORMONALLY RESISTANT PROSTATE-CANCER

Citation
Mj. Moore et al., USE OF PALLIATIVE END-POINTS TO EVALUATE THE EFFECTS OF MITOXANTRONE AND LOW-DOSE PREDNISONE IN PATIENTS WITH HORMONALLY RESISTANT PROSTATE-CANCER, Journal of clinical oncology, 12(4), 1994, pp. 689-694
Citations number
16
Categorie Soggetti
Oncology
ISSN journal
0732183X
Volume
12
Issue
4
Year of publication
1994
Pages
689 - 694
Database
ISI
SICI code
0732-183X(1994)12:4<689:UOPETE>2.0.ZU;2-F